UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

Small-area distribution of multiple sclerosis incidence in western France: in search of environmental triggers

International journal of health geographics, 2017-09, Vol.16 (1), p.35-35, Article 35

2017

Link zum Volltext

Verfügbarkeit prüfen

Aggressive multiple sclerosis. Definition and specific therapeutic indication

La Presse médicale (1983), 2004-02, Vol.33 (3), p.187

Edan, Gilles

2004

Link zum Volltext

Verfügbarkeit prüfen

Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

Proteomics (Weinheim), 2015-10, Vol.15 (19), p.3361-3369

2015

Link zum Volltext

Verfügbarkeit prüfen

Interrogation of the Multiple Sclerosis Prodrome Using High-Dimensional Health Data

Neuroepidemiology, 2020-03, Vol.54 (2), p.140-147

2020

Link zum Volltext

Verfügbarkeit prüfen

A 20-Year Incidence Trend (1989–2008) and Point Prevalence (March 20, 2009) of Multiple Sclerosis in Tehran, Iran: A Population-Based Study

Neuroepidemiology, 2011-06, Vol.36 (3), p.141-147

2011

Link zum Volltext

Verfügbarkeit prüfen

Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile

Journal of neurology, neurosurgery and psychiatry, 2008-02, Vol.79 (2), p.195-198

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis

International journal of molecular sciences, 2017-09, Vol.18 (10), p.2061

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients

Journal of clinical pharmacology, 2016-07, Vol.56 (7), p.845-851

2016

Link zum Volltext

Verfügbarkeit prüfen

Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study

Lancet neurology, 2017-06, Vol.16 (6), p.445-451

2017

Link zum Volltext

Verfügbarkeit prüfen

A case of multiple sclerosis with a tumefactive lesion during long-term treatment with fingolimod, leading to decompressive craniotomy

Rinsho shinkeigaku = Clinical neurology, 2023-01, Vol.63 (1), p.37

2023

Link zum Volltext

Verfügbarkeit prüfen

Geographical variations in sex ratio trends over time in multiple sclerosis

PloS one, 2012-10, Vol.7 (10), p.e48078-e48078

2012

Link zum Volltext

Verfügbarkeit prüfen

How common is truly benign MS in a UK population?

Journal of neurology, neurosurgery and psychiatry, 2019-05, Vol.90 (5), p.522

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of comorbidities on the course of multiple sclerosis

Clinical neurology and neurosurgery, 2018-04, Vol.167, p.76-81

2018

Link zum Volltext

Verfügbarkeit prüfen

Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod

Neurologia i neurochirurgia polska, 2017-03, Vol.51 (2), p.156-162

2017

Link zum Volltext

Verfügbarkeit prüfen

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

Lancet neurology, 2007-08, Vol.6 (8), p.677-686

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

Journal of magnetic resonance imaging, 2009-03, Vol.29 (3), p.537-544

2009

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study

Journal of neurology, neurosurgery and psychiatry, 2017-04, Vol.88 (4), p.285

2017

Link zum Volltext

Verfügbarkeit prüfen

Kappa free light chains: diagnostic and prognostic relevance in MS and CIS

PloS one, 2014-02, Vol.9 (2), p.e89945-e89945

2014

Link zum Volltext

Verfügbarkeit prüfen

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

American journal of neuroradiology : AJNR, 2016-03, Vol.37 (3), p.394-401

2016

Link zum Volltext

Verfügbarkeit prüfen

Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan

Canadian journal of neurological sciences, 2018-05, Vol.45 (3), p.295-303

2018

Link zum Volltext

Verfügbarkeit prüfen

A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway

Journal of neurology, neurosurgery and psychiatry, 2016-01, Vol.87 (1), p.100-105

2016

Link zum Volltext

Verfügbarkeit prüfen

Application of the 2017 McDonald criteria for the diagnosis of multiple sclerosis after a first demyelinating event in patients from Argentina

Multiple sclerosis and related disorders, 2020-06, Vol.41, p.102043-102043, Article 102043

2020

Link zum Volltext

Verfügbarkeit prüfen

Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?

PloS one, 2013-08, Vol.8 (8), p.e71894-e71894

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 156

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

ThemaNeurosciences

ThemaHumans

ThemaMiddle Aged

ThemaMultiple Sclerosis - Diagnosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(145)

Publikationsform

Artikel
(156)

Sprache

Erscheinungsjahr

n.n

Thema

Male
(150)
Science & Technology
(149)
Female
(148)
Adult
(140)
Multiple Sclerosis
(132)
Life Sciences & Biomedicine
(128)
Young Adult
(66)
Neurosciences & Neurology
(65)
Clinical Neurology
(64)
Adolescent
(57)
Aged
(48)
Magnetic Resonance Imaging
(40)
Neurology
(39)
Patients
(37)
Multiple Sclerosis - Epidemiology
(36)
Medicine
(31)
Radiology, Nuclear Medicine & Medical Imaging
(28)

12 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Small-area distribution of multiple sclerosis incidence in western France: in search of environmental triggers

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study

Aggressive multiple sclerosis. Definition and specific therapeutic indication

Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

Interrogation of the Multiple Sclerosis Prodrome Using High-Dimensional Health Data

A 20-Year Incidence Trend (1989–2008) and Point Prevalence (March 20, 2009) of Multiple Sclerosis in Tehran, Iran: A Population-Based Study

Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile

Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis

Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients

Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study

A case of multiple sclerosis with a tumefactive lesion during long-term treatment with fingolimod, leading to decompressive craniotomy

Geographical variations in sex ratio trends over time in multiple sclerosis

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

How common is truly benign MS in a UK population?

Effect of comorbidities on the course of multiple sclerosis

Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study

Kappa free light chains: diagnostic and prognostic relevance in MS and CIS

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan

A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway

Application of the 2017 McDonald criteria for the diagnosis of multiple sclerosis after a first demyelinating event in patients from Argentina

Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?

Aktive Filter

Suchergebnisse filtern